Glaukos Corp GKOS
News
Glaukos Announces Participation in Wells Fargo Healthcare Conference
Glaukos Announces Second Quarter 2026 Financial Results
Glaukos Announces Completion of Patient Enrollment in 510(k) Pivotal Study for PRESERFLO™ MicroShunt
Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29
Glaukos Shares Rise After FDA Approves NDA Supplement for iDose TR
